← Back to All Filings

Procter & Gamble Chief R&D Officer Receives Stock Option Grant

Low SignificanceSeptember 17, 2026 at 6:31:55 PM UTC

PROCTER & GAMBLE Co

$PG4CIK: 0000080424

Subscribe to track PG

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📊 Insider Grant: Procter & Gamble Co ($PG) Insider: Aguilar Moses Victor Javier (Chf Rsch, Dev & Innov Officer) Transaction Date: September 15, 2026 Security: Stock Option (Right to Buy) Type: Award/Grant | Shares: 3,519 @ $0.00 Exercise Price: $146.67 | Expiration Date: 2036-09-15 Post-Transaction Holdings: 3,519 options directly held; 49,511.09 common shares held directly.

Comprehensive Analysis

Overview

On September 17, 2026, Procter & Gamble Co ($PG) filed a Form 4 reporting an equity award granted to Victor Javier Aguilar Moses, Chief Research, Development & Innovation Officer.

Transaction Details

  • Date of Transaction: September 15, 2026
  • Transaction Code: A (Award / Grant)
  • Security: Stock Option (Right to Buy)
  • Number of Derivative Securities Granted: 3,519 options
  • Exercise Price: $146.67
  • Vesting / Exercise Date: September 14, 2029
  • Expiration Date: September 15, 2036
  • Total Consideration: $0 (Standard equity compensation grant)

Current Holdings

Following this transaction, the reporting officer holds:

  • Direct Derivative Holdings: 3,519 stock options
  • Direct Common Stock Holdings: 49,511.0935 shares
  • Indirect Common Stock Holdings:
    • 7,476.1294 shares via Retirement Plan Trustee
    • 428.6033 shares via International Stock Ownership Plan (Mexico) Trustee

Market & Governance Impact

This filing represents a routine annual equity incentive grant to an executive officer rather than open-market buying or selling activity. As a result, the market signaling effect is categorized as Low.

Topics:#PG#ProcterAndGamble#StockOptions#InsiderTrading#SECForm4

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.